The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
BAL: Exogenous (oil red O-stainable) lipids in BAL macrophages
Publications
Case 327: Exogenous Lipoid Pneumonia.
Radiology. 2024;312(1):e222280
Exogenous lipoid pneumonia: an important cause of interstitial lung disease in infants.
Respirology case reports. 2018;6(7):e00356
Lipoid pneumonia: an overview.
Expert review of respiratory medicine. 2010;4(6):799-807
Lipoid pneumonia presenting as non resolving community acquired pneumonia: a case report.
Cases journal. 2009;2:9332
[Lipoid pneumonia - an underestimated syndrome].
Deutsche medizinische Wochenschrift (1946). 2010;135(1-2):27-31
Lung infiltrate in a male with a bronchopleural fistula.
The European respiratory journal. 2003;21(6):1078-80
Images in clinical medicine. Exogenous lipoid pneumonia.
The New England journal of medicine. 1998;338(8):512
Bronchoalveolar lavage in liquid paraffin pneumonitis.
Chest. 1990;98(5):1149-55